This site is intended for health professionals only

Home / News / Anti-fluid retention medication recalled over contamination fears

Anti-fluid retention medication recalled over contamination fears


By Beth Kennedy
Editor-in-chief

14 Feb 2019

The manufacturer Actavis Group PTC EHF has recalled certain batches of ant-fluid retention medication over concerns they may have become contaminated with N-nitrosodiethylamine (NDEA).

Pharmacists should stop dispensing the affected batches, quarantine them and return all remaining stock to the supplier within 48 hours, the Medicines and Healthcare products Regulatory Agency (MHRA) said yesterday (13 February).

The affected batches are:

Irbesartan 300mg Film-coated tablets PL 30306/0108

Batch Number Expiry Date Pack Size First Distributed
  191018   05/2020   1 x 28   30 Nov 2018
  191118   05/2020  1 x 28   20 Dec 2018

Irbesartan / Hydrochlorothiazide 300 / 25mg Film-coated tablets, PL 30306/0267

Batch Number Expiry Date Pack Size First Distributed
  263918   06/2020   1 x 28   21 Nov 2018

Want news like this straight to your inbox?


Latest News

Pharmacies on track to deliver record 3 million flu vaccines
Community pharmacies in England could be on track to administer a record 3 million flu...
Covid booster pharmacy
More Covid booster jabs could be redirected to pharmacy
Community pharmacies in England could be given additional Covid booster vaccine appointments redirected from general...
CPCS
GPs to sign up to CPCS by December to access £250m cash injection
General practices in England are being encouraged to sign up to the community pharmacy consultation...